
Alphatec Holdings, Inc.
HealthcareNASDAQ:ATEC · NASDAQ Global Select
+$0.15 today
Vol 1.74M · Avg 3.20M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $139.9M |
| Receivables | $112.8M |
| Inventory | $186.0M |
| Other Current | $17.4M |
| Total Current Assets | $456.2M |
| PP&E (Net) | $168.6M |
| Goodwill | $74.5M |
| Intangible Assets | $90.0M |
| Other Non-current | $10.2M |
| Total Non-current Assets | $343.3M |
| Total Assets | $799.5M |
Analysis
Selected assets total $799.5M for Latest. The largest visible component is Inventory at $186.0M, about 23.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160.8M +15.8% | $138.8M -37.2% | $221.0M +160.9% | $84.7M -54.8% | $187.2M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $97.3M +17.3% | $83.0M +14.3% | $72.6M +20.9% | $60.1M +43.4% | $41.9M | $533.8M | $399.4M | -$1.7B |
| Inventory | $169.4M -3.3% | $175.3M +28.1% | $136.8M +34.8% | $101.5M +10.7% | $91.7M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $23.3M +14.8% | $20.3M -1.7% | $20.7M +120.9% | $9.4M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $450.9M +8.0% | $417.4M -7.5% | $451.1M +76.5% | $255.6M -22.8% | $331.2M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $166.5M -12.8% | $191.1M +8.4% | $176.2M +35.2% | $130.3M +15.6% | $112.7M | $1.2B | $1.5B | $687.8M |
| Goodwill | $75.2M +6.0% | $71.0M -2.8% | $73.0M +54.1% | $47.4M +19.3% | $39.7M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $93.5M -0.1% | $93.5M -8.7% | $102.5M +23.8% | $82.8M -2.9% | $85.3M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $5.1M +88.1% | $2.7M +12.6% | $2.4M -50.4% | $4.9M +50.0% | $3.2M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $340.3M -5.0% | $358.3M +1.2% | $354.1M +33.5% | $265.3M +10.1% | $240.9M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $791.2M +2.0% | $775.7M -3.7% | $805.2M +54.6% | $521.0M -8.9% | $572.1M | $13.3B | $11.9B | $10.6B |
| Account Payables | $40.9M -22.8% | $53.0M +8.2% | $49.0M +41.0% | $34.7M +35.0% | $25.7M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $70.8M +4176.8% | $1.7M -8.4% | $1.8M -87.9% | $14.9M +4270.8% | $342.0K | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $2.5M +26.2% | $2.0M +1.5% | $2.0M -34.9% | $3.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $10.4M -0.3% | $10.5M -24.8% | $13.9M +16.3% | $12.0M -21.6% | $15.3M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $63.7M +833.2% | $6.8M -87.9% | $56.5M +902.5% | $5.6M +31.3% | $4.3M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $219.2M +43.2% | $153.0M -2.9% | $157.6M +13.5% | $138.9M +37.4% | $101.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $525.3M -8.6% | $574.5M +12.4% | $511.0M +46.2% | $349.5M +7.1% | $326.5M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $2.2M -30.4% | $3.1M +22.3% | $2.6M -16.0% | $3.0M +5.2% | $2.9M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | -$15.3M -284.5% | $8.3M -4.0% | $8.6M -77.0% | $37.6M -0.3% | $37.8M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $536.0M -12.6% | $613.3M +12.3% | $545.9M +31.0% | $416.8M +6.4% | $391.5M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $755.2M -1.4% | $766.3M +8.9% | $703.5M +26.6% | $555.6M +12.8% | $492.6M | $14.7B | $3.7B | $9.6B |
| Common Stock | $15.0K +7.1% | $14.0K +0.0% | $14.0K +27.3% | $11.0K +10.0% | $10.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$1.4B -11.2% | -$1.3B -14.5% | -$1.1B -20.0% | -$932.3M -19.2% | -$782.3M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$4.4M +67.6% | -$13.7M -64.3% | -$8.3M +22.9% | -$10.8M -80.1% | -$6.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $36.0M +281.9% | $9.4M -90.7% | $101.7M +393.4% | -$34.7M -143.6% | $79.4M | $9.1B | $7.7B | $3.3B |
| Total Debt | $619.9M +1.6% | $609.9M +12.6% | $541.7M +36.8% | $395.9M +11.4% | $355.4M | $724.2M | $410.6M | $399.4M |
| Net Debt | $459.1M -2.5% | $471.1M +46.9% | $320.7M +3.1% | $311.2M +85.0% | $168.2M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector

Legend Biotech Corporation
NASDAQ:LEGN
$6.63B
Cidara Therapeutics, Inc.
CDTX
$5.61B

Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B

LivaNova PLC
NASDAQ:LIVN
$4.36B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B

Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.82B
Disc Medicine, Inc.
NASDAQ:IRON
$2.60B

IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B

Surgery Partners, Inc.
NASDAQ:SGRY
$2.00B

Zai Lab Limited
NASDAQ:ZLAB
$1.92B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ATEC have?
Alphatec Holdings, Inc. (ATEC) reported $160.81M in cash and equivalents in fiscal 2025.
How much debt does ATEC carry?
Alphatec Holdings, Inc. (ATEC) reported $619.95M of total debt, with net debt of $459.14M.
Explore More
Continue the stock analysis
Jump to another research area for this company.